M11.269
Other chondrocalcinosis, unspecified knee
Clinical Classification Guidelines
Medical Intelligence & Overview
Chondrocalcinosis of the knee is a condition characterized by the calcification of cartilage within the knee joint. Also known as calcium pyrophosphate dihydrate (CPPD) crystal deposition disease, this condition can lead to joint pain, swelling, and reduced mobility. When the exact cause can't be pinpointed, it is classified under 'unspecified' in medical coding, such as ICD-10 code M11.269. While sometimes asymptomatic, chondrocalcinosis can cause significant discomfort and impact daily activities.
Causes & Symptoms
Clinical Causes: Aging: The risk of chondrocalcinosis increases with age, as cartilage changes occur over time. Genetics: Family history may predispose individuals to develop CPPD deposits. Joint trauma: Previous injuries to the knee can contribute to crystal formation. Metabolic disorders: Conditions like hyperparathyroidism, hemochromatosis, and hypophosphatasia can increase the risk. Other joint diseases: Osteoarthritis and other cartilage disorders might be associated with crystal depositions.
Key Symptoms: Joint pain, especially during activity or at rest Swelling and warmth around the knee Stiffness, making movement difficult Reduced range of motion Possible episodes of acute joint inflammation resembling gout Recurring joint discomfort that may worsen over time
Diagnostic & Treatment
Diagnosis Path: X-ray imaging: Can reveal calcification in the cartilage structure of the knee. Joint aspiration: Extracting synovial fluid for crystal analysis under a microscope helps identify calcium pyrophosphate crystals. Blood tests: May be used to rule out other causes of joint inflammation and assess metabolic conditions. Medical history review: To evaluate risk factors like family history and previous joint injuries.
Treatment Protocols: Nonsteroidal anti-inflammatory drugs (NSAIDs): To alleviate pain and reduce inflammation. Colchicine: Sometimes recommended to prevent crystal formation and manage flare-ups. Corticosteroid injections: For significant swelling and pain relief within the joint. Physical therapy: Exercises and modalities to strengthen muscles around the knee and improve mobility. Lifestyle modifications: Weight management and activity adjustments to reduce joint stress. Monitoring and regular follow-up: To assess disease progression and effectiveness of treatments.
Clinical Advice & FAQs
Billing Guidance
Is M11.269 a billable ICD-10 code?
Yes, M11.269 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M11.269?
Clinical documentation must specify the nature of Other chondrocalcinosis, unspecified knee and any associated comorbidities for accurate reporting.
Cite this Clinical Reference